B-type natriuretic peptide prevents postnatal closure of ductus arteriosus by both vasodilation and anti-remodeling in neonatal rats

doi:10.1042/CS20180201

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 藥學系(所) > 期刊論文 > Item 310902800/32265

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32265

標題:	B-type natriuretic peptide prevents postnatal closure of ductus arteriosus by both vasodilation and anti-remodeling in neonatal rats
作者:	Yeh, Jwu-Lai Wu, Jiunn-Ren Wu, Bin-Nan Yang, Sheau-Fang Dai, Zen-Kong Liou, Shu-Fen Hsu, Jong-Hau
貢獻者:	Department of Pharmacology and Graduate Institute of Medicine, College of Medicine Department of Medical Research, Kaohsiung Medical University Hospital Kaohsiung Med Univ Hosp, Dept Med Res Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources Kaohsiung Med Univ Hosp, Dept Pediat Kaohsiung Med Univ, Coll Med, Fac Med, Dept Pediat I Shou Univ, E Da Hosp, Dept Pediat Kaohsiung Med Univ Hosp, Dept Pathol Chia Nan Univ Pharm & Sci, Dept Pharm
關鍵字:	Smooth-Muscle-Cells Labedipinedilol-A Proliferation Hypertension Mechanisms Pathway Aldosterone Activation Migration Aorta
日期:	2018-09-28
上傳時間:	2019-11-15 15:47:23 (UTC+8)
出版者:	PORTLAND PRESS LTD
摘要:	The physiologic process of postnatal ductus arteriosus (DA) closure consists of vasoconstriction followed by vascular remodeling. We have recently reported that B-type natriuretic peptide (BNP), a potent vasodilator, also has anti-remodeling effects in pulmonary vasculature. However, its effects on DA have not been elucidated. We investigated whether BNP can prevent DA closure, and if so, the underlying mechanisms. Using in vivo studies, we examined effects of BNP (10 mg/kg, ip at birth) on DA closure in neonatal rats within 4 h after birth. We found that in control rats, the DA spontaneously closed at 4 h with a decreased DA diameter, enhanced intimal thickening, and luminal occlusion. BNP prevented DA closure at 4 h with a preserved DA diameter, attenuated intimal thickening, and preserved lumina! patency. Ex vivo, BNP attenuated oxygen-induced vasoconstriction of isolated DA rings of newborn rats. These vasodilating effects were blunted by Rp-8-Br-PET-cGMPS, a cGMP inhibitor. In vitro, BNP inhibited angiotensin II (Ang II)-induced proliferation and migration of DA smooth muscle cells (DASMCs). BNP inhibited Ang II-induced mitochondrial reactive oxygen species (ROS) production and calcium overload in DASMCs. Finally, BNP inhibited Ang II-induced ERK1/2 activation. These in vitro effects were antagonized by Rp-8-Br-PET-cGMPS. In conclusion, BNP prevents postnatal DA closure by both vasodilation and anti-remodeling through the cGMP pathway. The mechanisms underlying anti-remodeling effects include anti-poliferation and anti-migration, with attenuation of mitochondrial ROS production and intracellular calcium and ERK1/2 signaling. Therefore, the BNP/cGMP pathway can be a promising therapeutic target for clinical management of DA patency.
link:	http://dx.doi.org/10.1042/CS20180201
關聯:	Plos One, v.132, n.18, pp.2045-2058
显示于类别:	[藥學系(所)] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	1529	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....